ES2084689T3 - Metodo para la averiguacion del sindrome de down. - Google Patents

Metodo para la averiguacion del sindrome de down.

Info

Publication number
ES2084689T3
ES2084689T3 ES90903086T ES90903086T ES2084689T3 ES 2084689 T3 ES2084689 T3 ES 2084689T3 ES 90903086 T ES90903086 T ES 90903086T ES 90903086 T ES90903086 T ES 90903086T ES 2084689 T3 ES2084689 T3 ES 2084689T3
Authority
ES
Spain
Prior art keywords
down syndrome
reference data
pregnant woman
chorionic gonadotropin
human chorionic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90903086T
Other languages
English (en)
Other versions
ES2084689T5 (es
Inventor
James N Macri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27540826&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2084689(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Individual filed Critical Individual
Publication of ES2084689T3 publication Critical patent/ES2084689T3/es
Application granted granted Critical
Publication of ES2084689T5 publication Critical patent/ES2084689T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/20—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for computer-aided diagnosis, e.g. based on medical expert systems
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
    • G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Medical Informatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Primary Health Care (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Immunology (AREA)
  • Data Mining & Analysis (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Geophysics And Detection Of Objects (AREA)
  • Image Processing (AREA)
  • Tests Of Electronic Circuits (AREA)
  • Paper (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

Abstract

SE PRESENTA UN METODO Y APARATO PARA DETERMINAR SI UNA MUJER GESTANTE TIENE UN RIESGO SIGNIFICANTE DE PORTAR UN FETO CON UN EL SINDROME DE DOWN. EL METODO COMPRENDE LA MEDIDA DE LOS NIVELES EN LA SANGRE DE LA MADRE QUE LA SUBUNIDAD BETA LIBRE DE GANADOTROPINA CORIONICA HUMANA. EL NIVEL DE LA SUBUNIDAD BETA LIBRE DE GANADOTROPINA CORIONICA HUMANA INDIVIDUALMENTE O CON OTROS MARCADORES PUEDE COMPARARSE CON DATOS DE REFERENCIA. TAMBIEN SE PRESENTA UN APARATO COMPUTERIZADO PARA EFECTUAR LA DETERMINACION, USANDO PREFERIBLEMENTE UNA FUNCION DE DENSIDAD DE PROBABILIDAD GENERADA A PARTIR DE UN CONJUNTO DE DATOS DE REFERENCIA MEDIANTE UN PROCEDIMIENTO DE ANALISIS DISCRIMINANTE LINEAL.
ES90903086T 1989-01-17 1990-01-16 Metodo para la averiguacion del sindrome de down. Expired - Lifetime ES2084689T5 (es)

Applications Claiming Priority (10)

Application Number Priority Date Filing Date Title
US29748189A 1989-01-17 1989-01-17
US297481 1989-01-17
US31180889A 1989-02-17 1989-02-17
US34937389A 1989-05-08 1989-05-08
US349373 1989-05-08
US36060389A 1989-06-02 1989-06-02
US360603 1989-06-02
US42077589A 1989-10-12 1989-10-12
US420775 1989-10-12
US311808 1994-09-26

Publications (2)

Publication Number Publication Date
ES2084689T3 true ES2084689T3 (es) 1996-05-16
ES2084689T5 ES2084689T5 (es) 2005-03-01

Family

ID=27540826

Family Applications (2)

Application Number Title Priority Date Filing Date
ES90903086T Expired - Lifetime ES2084689T5 (es) 1989-01-17 1990-01-16 Metodo para la averiguacion del sindrome de down.
ES95104733T Expired - Lifetime ES2210266T3 (es) 1989-01-17 1990-01-16 Aparato para detectar el sindrome de down por medio de un examen no invasivo de sangre materna.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES95104733T Expired - Lifetime ES2210266T3 (es) 1989-01-17 1990-01-16 Aparato para detectar el sindrome de down por medio de un examen no invasivo de sangre materna.

Country Status (9)

Country Link
US (1) US5324668A (es)
EP (2) EP0666477B1 (es)
JP (1) JP2644373B2 (es)
AT (2) ATE252240T1 (es)
AU (1) AU629908B2 (es)
DE (2) DE69026153T3 (es)
DK (2) DK0666477T3 (es)
ES (2) ES2084689T5 (es)
WO (1) WO1990008325A1 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5324667A (en) * 1989-01-17 1994-06-28 Macri James N Method for detecting down sydrown by non-invasive maternal blood screening
WO1990008325A1 (en) * 1989-01-17 1990-07-26 Macri James N Down syndrome screening method
US5252489A (en) * 1989-01-17 1993-10-12 Macri James N Down syndrome screening method utilizing dried blood samples
US5668117A (en) * 1991-02-22 1997-09-16 Shapiro; Howard K. Methods of treating neurological diseases and etiologically related symptomology using carbonyl trapping agents in combination with previously known medicaments
GB9224965D0 (en) * 1992-11-28 1993-01-20 Kodak Ltd Antenatal screening for chromosomal abnormalities
GB9306354D0 (en) * 1993-03-26 1993-05-19 Kodak Ltd Antenatal screening for chromosomal abnormalities
GB9315230D0 (en) * 1993-07-22 1993-09-08 Kodak Ltd Antenatal screening for chromosomal abnormalities
US5583612A (en) * 1994-07-14 1996-12-10 Xerox Corporation Flexible latch with relaxed engagement
JP3703858B2 (ja) * 1993-09-30 2005-10-05 シスメックス株式会社 帰属度判別装置
GB9416415D0 (en) * 1994-08-13 1994-10-05 Kodak Ltd Antenatel screening for pregnacy abnormalities
US5606164A (en) * 1996-01-16 1997-02-25 Boehringer Mannheim Corporation Method and apparatus for biological fluid analyte concentration measurement using generalized distance outlier detection
GB9606261D0 (en) * 1996-03-25 1996-05-29 Johnson & Johnson Clin Diag Prenatal screening for fetal abnormalities
US5888740A (en) * 1997-09-19 1999-03-30 Genaco Biomedical Products, Inc. Detection of aneuploidy and gene deletion by PCR-based gene- dose co-amplification of chromosome specific sequences with synthetic sequences with synthetic internal controls
PT1076824E (pt) 1998-04-29 2006-10-31 Wald Nicholas John Avaliacao pre-natal do sindroma de down
US7041466B2 (en) * 2002-08-05 2006-05-09 Auburn University Mouse disease model for evaluation of prophylactic and therapeutic treatments of Chlamydia
US7315787B2 (en) * 2003-10-07 2008-01-01 Ntd Laboratories, Inc. Multi-marker screening protocol for fetal abnormalities
EP1689884A4 (en) * 2003-10-08 2007-04-04 Univ Boston PROCESS FOR THE PRENATAL DIAGNOSIS OF CHROMOSOMAL ABNORMALITIES
AU2006226891A1 (en) * 2005-03-24 2006-09-28 Beth Israel Deaconess Medical Center Methods of diagnosing fetal trisomy 13 or a risk of fetal trisomy 13 during pregnancy
WO2008052221A2 (en) * 2006-10-27 2008-05-02 Aretais, Inc. Use of coherent raman techniques for medical diagnostic and therapeutic purposes, and calibration techniques for same
WO2011144999A1 (en) 2010-05-17 2011-11-24 Sandra Reznik Plasma protein-a2 (papp-a2) as a marker for detecting risk of chromosomal abnormalities
CN103076458A (zh) * 2012-12-16 2013-05-01 北京利德曼生化股份有限公司 游离人绒毛膜促性腺激素β亚单位磁微粒化学发光法定量测定试剂盒及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4016250A (en) * 1974-03-22 1977-04-05 Cornell Research Foundation, Inc. Method for testing for pregnancy
US4123224A (en) * 1975-12-17 1978-10-31 American Home Products Corporation Diagnostic test device
JPS54126723A (en) * 1978-03-23 1979-10-02 Teikoku Hormone Mfg Co Ltd Preparation of specific hcg and specific anti-hcg-beta-subunit antibody
DE3112767A1 (de) * 1981-03-31 1982-11-11 Werner Dr.med. 1000 Berlin Steinschulte Heimcomputer zur natuerlichen familienplanung (nfp) und zur gynaekologisch-endokrinologischen diagnostik
US4565687A (en) * 1981-11-16 1986-01-21 The Reagents Of The University Of Michigan Monoclonal antibodies specific for the unbound β subunit of human chorionic gonadotropin
GR850899B (es) * 1984-04-12 1985-11-25 Gen Hospital Corp
US4874693A (en) * 1986-10-10 1989-10-17 Mark Bogart Method for assessing placental dysfunction
JP2525474B2 (ja) * 1987-07-09 1996-08-21 ３アイ・リサーチ・エクスプロイテーション・リミテッド 胎児のダウン症候群を検出する方法およびその装置
US5037305A (en) * 1988-11-16 1991-08-06 Vivigen, Inc. Graphic method for reporting risk to a patient
WO1990008325A1 (en) * 1989-01-17 1990-07-26 Macri James N Down syndrome screening method

Also Published As

Publication number Publication date
JP2644373B2 (ja) 1997-08-25
JPH03505128A (ja) 1991-11-07
ES2084689T5 (es) 2005-03-01
DE69034111T2 (de) 2004-07-29
EP0409956A1 (en) 1991-01-30
AU5093690A (en) 1990-08-13
DE69026153D1 (en) 1996-05-02
ES2210266T3 (es) 2004-07-01
AU629908B2 (en) 1992-10-15
EP0666477B1 (en) 2003-10-15
DE69034111D1 (de) 2003-11-20
US5324668A (en) 1994-06-28
ATE136121T1 (de) 1996-04-15
EP0409956B2 (en) 2004-07-21
DE69026153T3 (de) 2005-05-12
DK0409956T4 (da) 2004-09-06
EP0409956B1 (en) 1996-03-27
DK0409956T3 (da) 1996-04-29
EP0666477A1 (en) 1995-08-09
ATE252240T1 (de) 2003-11-15
WO1990008325A1 (en) 1990-07-26
DK0666477T3 (da) 2004-02-23
DE69026153T2 (de) 1996-09-19

Similar Documents

Publication Publication Date Title
ATE136121T1 (de) Downsyndrom-screening-methode
Bree et al. Transvaginal sonography in the evaluation of normal early pregnancy: correlation with HCG level
Sterzik et al. Doppler sonographic findings and their correlation with implantation in an in vitro fertilization program
O'Brien et al. Growth of the ultrasound fetal femur length during normal pregnancy: part I
Jeanty et al. Ultrasonic evaluation of fetal ventricular growth
FitzSimmons et al. Long-bone growth in fetuses with Down syndrome
DE3776190D1 (de) Dreidimensionaler digitalumformer zur skelettanalyse.
ATE132026T1 (de) Vorrichtung zur bildformung kleiner kavitäten
DE69030832D1 (de) Automatische Analysevorrichtung und Verfahren für klinische Untersuchung
Kurtz et al. In utero analysis of heterozygous achondroplasia: variable time of onset as detected by femur length measurements.
EP0233724A3 (en) Ultrasonic probe for medical diagnostic examination
ATE412896T1 (de) Pränatales down-syndrom-testverfahren unter benutzung von hyperglykosyliertem gonadotropin
Hoidas et al. Scoring sperm morphology from fertile and infertile cigarette smokers using the scanning electron microscope and image analysis
Honda et al. An MRI study on the relationship between oral cavity shape and larynx position
McCloskey et al. Chemical composition of the rabbit aorta during development
PT80743A (fr) Sonde et procede pour le diagnostic du sexe d'un embryon humain
Lewin et al. Measuring the height of a cephalic presentation: an objective assessment of station
DK115489D0 (da) Foerfoedselscreening for down's syndrom
Bergsjø et al. Interindividual variation in vaginal examination findings during labor
Wright Syphilis and Neanderthal man
CAMPBELL et al. Erythropoietin levels in amniotic fluid and extraembryonic coelomic fluid in the first trimester of pregnancy
DODO Appearance of bony bridging of the hypoglossal canal during the fetal period
Stoz et al. The development of the placental villus during normal pregnancy: morphometric data base
ATE117090T1 (de) Verfahren zur diagnose von tumoren.
ATE180644T1 (de) Vorgeburtliche überprüfung von missbildungen der chromosomen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 409956

Country of ref document: ES